Nuwellis, Inc. announced preliminary unaudited revenue growth of 14% year-over-year for the second quarter ended June 30. This indicates strong financial performance for the period.
Nuwellis Reports 14% Revenue Growth in Preliminary Q2 2026 Results
earnings reportrevenue growthbiotech stocksquarterly resultsfinancial performance



